Stock Updates

How has Edwards Lifesciences Corp.:(NYSE:EW) performed recently?

Edwards Lifesciences Corp. (NYSE: EW) is a large market cap stock with a market cap of 23929.02. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 48.14, a forward P/E of 34.5 and EPS of 2.35. At a stock price of 114.57 (1.40%) it has a dividend yield of *TBA.

EPS growth for the last five years have been 19.70%, more recently this last year it has grown by -39.80%. The next year growth is going to be about 18.53% and more long-term 16.82% after five years. EPS growth quarter over quarter is 17.40%. Sales growth for the past five years have been 11.50% and sales growth quarter over quarter is 18.10%.

For performance, Edwards Lifesciences Corp. the past week has seen a gain of 6.33%. For the last month performance for Edwards Lifesciences Corp. is 18.97%. While the last quarter is 5.35% and half year, 48.91%. Finally for the year, performance is 46.97%.

The 52-week high for Edwards Lifesciences Corp., is at -2.46%, and for the 52-week low it comes to a value of 83.22%. The 20-day simple moving average is 12.39% and 27.13% for the 200-day simple moving average.

Volatility for the week is at 1.97%, and for the month it is 1.86%. Edwards Lifesciences Corp., has a target price of 116.86.

In terms of debt, long term debt/equity is 0.26, and for total debt/equity Edwards Lifesciences Corp. has 0.26. The gross margin is 74.60%, while operating margin is 24.70%, the profit margin is 19.80%. The current ratio is 4 and the quick ratio is 3.2.

Insider ownership is at 0.40%, with instituitional ownership at 87.70%. Edwards Lifesciences Corp. has a payout ratio of 0.00%. With the total shares outstanding coming to 211.78. The shares float is 210.17, with the float short at 1.73%, with short ratio coming to 2.13.

In terms of returns, the return on assets see Edwards Lifesciences Corp., get 13.40%, with its returns on investment at 15.90%. Return on equity is 21.60%. So will the investors see the target price of 116.86, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Stephen Butters

Leave a Comment